Healthy Skepticism Library
Items published during the years 1980 to 1989
There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.
Page 8 of 11 pages ‹ First < 6 7 8 9 10 > Last ›
HSL20337
Elstein AS, Dawson-Saunders B, Belzer LJ
Instruction in Medical Decision Making
Med Decis Making 1985; 5:(2):228-233
http://mdm.sagepub.com/content/5/2/229.extract
HSL20525
Inman WHW
Let's get our act together
Side Effects of Drugs Annual 1985; 9: xv–xxiii
http://www.sciencedirect.com/science/article/pii/S0378608085800040
HSL20539
Dukes MNG
Pharmaceuticals: Take Another Look
Pharmaceut. Med. 1985; 1:117-127
HSL11490
Drug Maker Pleads Guilty Over Lethal Side Effects
Associated Press 1984 Dec 14
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9501E2DF1338F937A25751C1A962948260
HSL8384
White JP.
Prescriptions: growth, gyrations, generics
Drug Topics 1984 Dec 10; 128:46, 48-49, 52
HSL8393
Limited list prescribing: ABPI begins campaign against stupid and dangerous proposal
Pharmaceutical Journal 1984 Dec 8; 233:712-713
HSL3188
Collier J.
Unconvincing reassurance from the ABPI.
Lancet 1984 Dec 1; 2:(8414):1280
HSL3253
Re: the promotion of Binotal
1984 Dec 01;
HSL8379
Schwartz H.
Are doctors' offices troubled waters for the industry?
Pharmaceutical Executive 1984 Dec; 4:14, 16
HSL20478
Fowler J
'War' on the drug firms who cheat
Daily News 1984 Nov 2310
HSL20479
Fighting killer drugs
The West Australian 1984 Nov 2131
HSL3186
Collier J.
Misleading advertisements: sanctions and corrections.
Lancet 1984 Nov 10; 2:(8411):1097-8
HSL3197
Statement on ethical conduct in research by the Infectious Diseases Society of America.
J Infect Dis. 1984 Nov 01; 150:(5):792-3
HSL8394
Pharmaceutical R&D must be encouraged and supported, CMA tells the Eastman Commission
Canadian Medical Association Journal 1984 Nov 1; 131:1095-1097
HSL8395
Give us more protection, innovative drug manufacturers tell Eastman Commission
Canadian Medical Association Journal 1984 Nov 1; 131:1097-1098
HSL3225
Yudkin JS.
Use and misuse of drugs in the Third World.
Dan Med Bull 1984 Nov; 31:
HSL8375
Schwartz H.
There's no profit in misunderstanding
Pharmaceutical Executive 1984 Nov; 4:14, 16-17
HSL8376
Shuler J.
Indirect Rx advertising to consumers
Pharmaceutical Executive 1984 Nov; 4:10
HSL8381
Schaaf D.
Hospital pharmacy and industry-rivals or partners
Krankenhauspharmazie 1984 Nov; 5:347-351
HSL8397
Buchanan C.
Requiring rational promotions as part of a bid request
American Journal of Hospital Pharmacy 1984 Nov; 41:2320, 2324
HSL20224
Andrews G
On the promotion of non-drug treatments
BMJ 1984 Oct 13; 289:
http://www.bmj.com/content/289/6450/994
HSL20483
MLAM
Round the World: From our Correspondents: Australia: MLAM
Lancet 1984 Oct 13; 861
HSL3212
Rawlins MD.
Doctors and the drug makers.
Lancet 1984 Oct 6; 2:(8406):814
HSL3252
Gabe L.
You can reach the hard-to-see MD!
Medical Marketing & Media 1984 Oct; 19:63, 66, 68-69
HSL8383
Merchandising alert: new items push sales out front
National Association of Retail Druggists Journal 1984 Oct; 106:10-11
HSL8391
Thompson RC.
Flaw in cytotoxic testing: there's no proof it works
FDA Consumer 1984 Oct; 18:34-36
HSL3200
Lexchin J.
Pharmaceutical advertising in medical journals.
Can Med Assoc J 1984 Sep 15; 131:(6):544-6
HSL3179
Some dodgy claims for pirbuterol (Exirel)--a beta 2 agonist.
Drug Ther Bull. 1984 Sep 10; 22:(18):70-2
HSL8386
Rockwell T.
Rx ads to consumers at the threshold
Pharmaceutical Executive 1984 Sep; 4:52, 54, 58
HSL8387
Prescription drug prices soar after years of moderate increases
American Pharmacy 1984 Sep; 16-17
HSL8388
Abbott B.
Getting your OTC campaign in shape
Pharmaceutical Executive 1984 Sep; 4:60, 62, 67
HSL8389
Fisher JJ.
Cautiously circling the issue of Rx consumer ads
Pharmaceutical Executive 1984 Sep; 4:46, 50-51, 102
HSL8400
Jenne JW.
Unintentional overdose of theophylline: challenge to the pharmaceutical industry.
Clin Pharm 1984 Sep-Oct; 3:(5):523-4
HSL3251
Joubert PH, Skene D.
Attitudes of private medical practitioners towards package inserts and other drug information sources.
S Afr Med J 1984 Aug 25; 66:(8):306-7
http://www.ncbi.nlm.nih.gov/pubmed/6474294
HSL3246
Altman L.
Dealing with conflicts of interest [4th of 4 letters]
New England Journal of Medicine 1984 Aug 9; 311:(6):405
HSL3247
Cohen SM.
Dealing with conflicts of interest [1st of 4 letters]
New England Journal of Medicine 1984 Aug 9; 311:(6):404
HSL3248
Goldstone RA.
Dealing with conflicts of interest [2nd of 4 letters]
New England Journal of Medicine 1984 Aug 9; 311:(6):404
HSL3249
Nightingale SD, Ansell D, Cohen M, Danel I, Hoffman A, Kiken S, Orris P, Patch O, Ringel P, Sable R, Schiff G, Schiff R, Sherer R, Shansky R, Trainor W, Tully J, Watson C, Kallal C.
Dealing with conflicts of interest [3rd of 4 letters]
New England Journal of Medicine 1984 Aug 9; 311:(6):404-405
HSL3250
Relman AS.
Dealing with conflicts of interest [Editor's reply]
New England Journal of Medicine 1984 Aug 9; 311:(6):405
HSL8392
Hildebrand N.
Physician and pharmacist: competing or essentially complementing?
Deutsche Apotheker Zeitung 1984 Aug 9; 124:1573-1576
HSL8374
Final judgement on advertising-U.S. district court
American Pharmacy 1984 Aug; 74-76
HSL3244
Collier JG, Pilkington TRE.
Human insulin: a misleading advertisement?
British Medical Journal 1984 Jul 21; 289:191
HSL3245
Knight RK, Gennery BA.
Human insulin: a misleading advertisement? [reply]
British Medical Journal 1984 Jul 21; 289:191
HSL3222
Wolffers I.
Telling doctors in a developing country about phenylbutazone.
Lancet 1984 Jul 7; 2:(8393):44
HSL3241
MLAM’s first six months
MLAM Newsletter 1984 Jul 011-2
HSL3242
Re: the promotion of ethylestrenol
1984 Jul 01;
HSL3237
Mastroni N.
The industry is tuning out on direct-to-consumer advertising.
Med Mark Media 1984 Jul; 19:(7):10-1,
HSL3243
Gouveia WA.
Hospital pharmacy and industry--conflict and collaboration.
Am J Hosp Pharm 1984 Jul; 41:(7):1391-4
HSL13250
Adelson B.
When novices surpass experts: The difficulty of a task may increase with expertise.
Journal of Experimental Psychology: Learning, Memory, and Cognition 1984 Jul; 10:(3):483-495
http://content.apa.org/journals/xlm/10/3/483
HSL20533
Herxheimer A.
Immortality for old drugs?
The Lancet 1984 Jun 30; 1:(8392):1460-1.
http://www.ncbi.nlm.nih.gov/pubmed/6145891
HSL20526
Health minister recieves rational health declaration
The Lancet 1984 Jun 16; (i):1172-73
HSL20527
The People's Health
The Lancet 1984 Jun 16; (i):1172-73
HSL3180
Bansinath M, Sequeira RP, Shukla VK, Mathur VS.
Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint.
Int J Clin Pharmacol Ther Toxicol 1984 Jun; 22:(6):279-83
HSL8404
Rantucci M, Segal HJ.
Public awareness: assessment of the public response to a display illustrating community pharmacists' roles and services
Canadian Pharmaceutical Journal 1984 Jun; 117:272-275
HSL8405
Gunston G.
Pharmaceutical marketing: but my market is different
Pharmaceutical Journal 1984 May 12; 232:588-589
HSL3238
Re: the promotion of Lomotil
1984 May 01;
HSL3239
Donald AG.
Doctors and the pharmaceutical industry
Journal of the Royal College of General Practitioners 1984 May; 34:301
HSL3240
Liebman M.
Prescription drug advertising to the general public.
Hosp Pract (Off Ed) 1984 May; 19:(5):13,
HSL13372
Gallus M.
Under The Sugar Coating
The Globe and Mail (Canada) 1984 Apr 21
HSL3192
Crompton GK, Grant IW.
Pirbuterol.
Lancet 1984 Apr 7; 1:(8380):795
HSL3234
Re: the promotion of dipyrone
1984 Apr 01;
HSL3235
Physicians, pharmacists, and consumers react to a direct-to-consumer campaign
Medical Marketing & Media 1984 Apr 01; 19:(4):24, 26
HSL3218
Tse CS, Mansur JM.
Drug industry response time.
Drug Intell Clin Pharm 1984 Apr; 18:(4):325
HSL3236
Atkinson AJ Jr, Becker RE, Galletti PM, Jefferis JE, Wroblewski R.
University and pharmaceutical industry cooperation: the need to plan for the future.
Clin Pharmacol Ther 1984 Apr; 35:(4):431-7
HSL3185
Collier J.
The Medicines Act and the ABPI code.
Lancet 1984 Mar 24; 1:(8378):682-3
HSL8399
Maclay WP, Crowder D, Spiro S, Turner P.
Postmarketing surveillance: practical experience with ketotifen.
Br Med J (Clin Res Ed) 1984 Mar 24; 288:(6421):911-4
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=6423140
HSL3233
Urbanski A.
Drug marketers write an Rx for consumers
Sales & Marketing Management 1984 Mar 12; 132:74-75, 78
HSL8408
Spink JD.
Parallel imports
Pharmaceutical Journal 1984 Mar 10; 232:275-276
HSL3190
Cox P.
Rules of conduct and the pharmaceutical industry.
Lancet 1984 Mar 3; 1:(8375):517
HSL3232
Coffman K.
Drug companies can help educate your patients . . . if only you’d let them
Canadian Doctor 1984 Mar33-35
HSL3187
Collier J.
Rules of conduct and the pharmaceutical industry.
Lancet 1984 Feb 25; 1:(8374):453
HSL3189
Collier J, New L.
Illegibility of drug advertisements.
Lancet 1984 Feb 11; 1:(8372):341-2
HSL3231
Murphy DH.
Direct to consumer advertising of prescription drugs. FDA's first round of tests
Am Pharm. 1984 Feb 01; 24:(2):20-3
HSL3230
Manners S.
All the news that’s fit to print: dealing with what your patients read
Canadian Doctor 1984 Feb36-39
HSL3228
Cousins J.
Payments to doctors and the responsibilities of ethics committees [2nd of 2 letters]
British Medical Journal 1984 Jan 28; 288:323
HSL3229
Diamond A, Robinson K.
Payments to doctors and the responsibilities of ethics committees [1st of 2 letters]
British Medical Journal 1984 Jan 28; 28:322-323
HSL3226
Survey: Consumers don't favor prescription drug advertising
American Pharmacy 1984 Jan 01; 24:(1):10
HSL3198
Kunin CM.
The relation between clinical investigators and the pharmaceutical industry.
Rev Infect Dis 1984 Jan-Feb; 6:(1):129-31
HSL3227
Powell SH, Stempien MJ, Vogenberg FR.
Hospital-based training for pharmaceutical manufacturers' representatives.
Am J Hosp Pharm 1984 Jan; 41:(1):70,
HSL8441
Bass MA.
Look alikes: methinks the brand name companies protest too much
Pharmaceutical Executive 1984 Jan; 4:42-43
HSL8444
Survey: consumers don't favor prescription drug advertising
American Pharmacy 1984 Jan; 10
HSL2040
Braithwaite J.
Corporate crime in the pharmaceutical industry.
London: Routledge & Kegan Paul 1984
http://www.amazon.com/exec/obidos/tg/detail/-/0710200498/qid=1124498017/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books
HSL3175
Advertiser wins CMAJ award
Canadian Medical Association Journal 1984; 131:58
HSL3176
Drug companies at a European congress
Lancet 1984; 2:1031
HSL3177
MLAM
Lancet 1984; 2:861
HSL3178
Organon censured for marketing of anabolic steroids in developing countries
Lancet 1984; 1:155
HSL3181
Bass MJ.
Chairman’s chair: research or marketing?
Family Medicine Research Update 1984; 3:(2):6-7
HSL3182
Berner MS.
‘Misleading’ drug ad
Canadian Family Physician 1984; 30:271-272
HSL3183
Buckley EG.
Preventing promotion
Journal of the Royal College of General Practitioners 1984; 37:473
HSL3184
Burley DM, Thomson TJ
Doctors and the drug makers
Lancet 1984; 2:404-405
HSL3191
Cox PJ.
Doctors and the drug makers
Lancet 1984; 2:580
HSL3193
Hemminki E, Enlund H, Hellevuo K, Laurila R, Turakka H.
Trade names and generic names: Problems for prescribing physicians
Scandinavian Journal of Primary Health Care 1984; 2:84-87
HSL3194
Henderson IWD.
Pharmaceutical advertising in medical journals
Canadian Medical Association Journal 1984; 131:546
HSL3195
Herdman RC.
University-Industrial Relationships.
Cancer Invest 1984; 2:(1):61-6
HSL3196
Hoff LC.
Advertising prescription drugs direct to the public: What are the issues?
Vitsl Speeches of the Day 1984; 50:573-576
HSL3199
Laporte JR, Porta M, Capella D, Arnau JM.
Drugs in the Spanish health system.
Int J Health Serv 1984; 14:(4):635-48
HSL3201
Lexchin J.
Reader upset at CFPC’s involvement in prescribing survey
Canadian Family Physician 1984; 30:1454
HSL3202
Lexchin J.
The real pushers: a critical analysis of the Canadian drug industry
1984;
HSL3203
Massam ADW.
Legibility of advertisements
Lancet 1984; 2:1397
HSL3204
Massam ADW.
Misleading advertisements
Lancet 1984; 2:1159
Page 8 of 11 pages ‹ First < 6 7 8 9 10 > Last ›
